Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway-Reference-Cited by-同舟云学术

Periplocin inhibits hepatocellular carcinoma progression and reduces the recruitment of MDSCs through AKT/NF-κB pathway

Published:2023-07 Issue: Volume:324 Page:121715
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Lin Jia-Peng,Huang Mao-Hua,Sun Zhi-Ting,Chen Lei,Lei Yu-He,Huang Yu-Qing,Qi Ming,Fan Shu-Ran,Chen Shou-Guo,Chung Chi-Wing,Chan Mei-Ching,Liu Jun-Shan,Hu Min,Chen Min-Feng,Ye Wen-Cai,Chen Yue-Yue,Deng Li-Juan

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference28 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J. Clin.,2021

2. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma;Feng;J. Exp. Clin. Cancer Res.,2020

3. Liver cancer cell of origin, molecular class, and effects on patient prognosis;Sia;Gastroenterology,2017

4. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma;Yeo;J. Natl. Cancer Inst.,2005

5. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma;Bruix;Gastroenterology,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Periplocin improves the sensitivity of oxaliplatin-resistant hepatocellular carcinoma cells by inhibiting M2 macrophage polarization;Biomolecules and Biomedicine;2024-08-27

2. CXCL3: A key player in tumor microenvironment and inflammatory diseases;Life Sciences;2024-07

3. Network toxicology, molecular docking technology, and experimental verification revealed the mechanism of cantharidin-induced testicular injury in mice;Toxicology and Applied Pharmacology;2024-05

4. Mouse models for cancer research – current state and the perspective;Neoplasma;2024